Dr. Reddys Laboratories (RDY)
(Delayed Data from NYSE)
$79.51 USD
+0.03 (0.04%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $79.50 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 10/25/24 |
---|---|
Current Quarter | 0.99 |
EPS Last Quarter | 1.00 |
Last EPS Surprise | -9.09% |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 4.11 |
Next Year | 4.13 |
EPS (TTM) | 4.00 |
P/E (F1) | 19.34 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 879.45M | 896.10M | 3.64B | 3.83B |
# of Estimates | 1 | 1 | 3 | 3 |
High Estimate | 879.45M | 896.10M | 3.77B | 4.14B |
Low Estimate | 879.45M | 896.10M | 3.55B | 3.63B |
Year ago Sales | 832.16M | 867.00M | 3.37B | 3.64B |
Year over Year Growth Est. | 5.68% | 3.36% | 8.10% | 5.09% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.99 | 1.00 | 4.11 | 4.13 |
# of Estimates | 1 | 1 | 4 | 4 |
Most Recent Consensus | NA | NA | 3.99 | 4.05 |
High Estimate | 0.99 | 1.00 | 4.33 | 4.59 |
Low Estimate | 0.99 | 1.00 | 3.86 | 3.66 |
Year ago EPS | 1.07 | 0.99 | 4.01 | 4.11 |
Year over Year Growth Est. | -7.48% | 1.01% | 2.49% | 0.36% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Current | 0.99 | 1.00 | 4.11 | 4.13 |
7 Days Ago | 0.99 | 1.00 | 4.11 | 4.13 |
30 Days Ago | 0.99 | 1.00 | 4.11 | 4.13 |
60 Days Ago | 0.99 | 1.00 | 4.03 | 3.86 |
90 Days Ago | 0.99 | 1.00 | 4.03 | 3.91 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.99 | 1.00 | 4.11 | 4.13 |
Zacks Consensus Estimate | 0.99 | 1.00 | 4.11 | 4.13 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.00 | 0.94 | 0.99 | 1.07 | NA |
Estimate | 1.10 | 0.86 | 0.87 | 0.88 | NA |
Difference | -0.10 | 0.08 | 0.12 | 0.19 | 0.07 |
Surprise | -9.09% | 9.30% | 13.79% | 21.59% | 8.90% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more